21 April 2023>: Original Paper
Converting from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in Patients with Hepatitis B Following Liver Transplantation
Chih-Hsien Cheng ABCDE , Hao-Chien Hung BC , Jin-Chiao Lee BC , Yu-Chao Wang CD , Tsung-Han Wu CD , Chen-Fang Lee ABC , Ting-Jung Wu BC , Hong-Shiue Chou BC , Kun-Ming Chan BC , Wei-Chen Lee ABCD*DOI: 10.12659/AOT.938731
Ann Transplant 2023; 28:e938731
Figure 4 Renal function change during therapy with TDF and TAF after stratifying by stages of chronic kidney disease(A) Median and IQR eGFR and (B) eGFR percent change from baseline at weeks 12, 24, 36 and 48 during TDF and TAF therapy. (C) eGFR percent change of stage 3b and 4 patients during TAF. n.s. – not significant, *** p<0.001 (one-way ANOVA).